SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2020-06, Vol.34 (6), p.e254-e255 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e255 |
|---|---|
| container_issue | 6 |
| container_start_page | e254 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 34 |
| creator | Messina, F. Piaserico, S. |
| description | |
| doi_str_mv | 10.1111/jdv.16468 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7262156</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JDV16468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4438-187fb8a930241bc5bf55058cb936006c3d39c5ed18f4c97d2fecc99ba8ab860c3</originalsourceid><addsrcrecordid>eNp1kMtOAjEUhhujEUQXvoCZrYuBXqal3ZgQvGGIJqJsm7bTkRKYmXRGCDsfwWf0SSyOEl3YxTlN-p2vJz8Apwh2UTi9ebrqIpYwvgfaKLSYQE72QRsKzGIhqGiBo6qaQwgRovwQtAjGIsGUt8H9ZPA4-Xh7HxbTUHHk8sya2hV5uEUqKqvCO1U7E5Wh2ryOam9VbdNo7epZNBpvh0hgZ067uvDH4CBTi8qefPcOeL6-ehrexuOHm9FwMI5NkhAeI97PNFeCQJwgbajOKIWUGy0Ig5AZkhJhqE0RzxIj-ikOSxkhtOJKcwYN6YCLxlu-6qVNTdjMq4UsvVsqv5GFcvLvS-5m8qVYyT5mGFEWBOeNwPiiqrzNdrMIym2oMoQqv0IN7Nnvz3bkT4oB6DXA2i3s5n-TvLucNspP_SmEqA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Messina, F. ; Piaserico, S.</creator><creatorcontrib>Messina, F. ; Piaserico, S.</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.16468</identifier><identifier>PMID: 32294258</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Adult ; Arthritis, Psoriatic - diagnosis ; Arthritis, Psoriatic - drug therapy ; Arthritis, Psoriatic - immunology ; Biological Products - administration & dosage ; Biological Products - adverse effects ; Clinical Laboratory Techniques ; Coronavirus Infections - diagnosis ; Coronavirus Infections - immunology ; COVID-19 ; COVID-19 Testing ; Covid‐19 Special Forum ; False Negative Reactions ; Female ; Follow-Up Studies ; Humans ; Immunocompromised Host - immunology ; Interleukin-23 - antagonists & inhibitors ; Italy ; Pandemics ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - immunology ; Psoriasis - diagnosis ; Psoriasis - drug therapy ; Psoriasis - immunology ; Risk Assessment ; Severe Acute Respiratory Syndrome - diagnosis ; Severe Acute Respiratory Syndrome - therapy</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2020-06, Vol.34 (6), p.e254-e255</ispartof><rights>2020 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4438-187fb8a930241bc5bf55058cb936006c3d39c5ed18f4c97d2fecc99ba8ab860c3</citedby><cites>FETCH-LOGICAL-c4438-187fb8a930241bc5bf55058cb936006c3d39c5ed18f4c97d2fecc99ba8ab860c3</cites><orcidid>0000-0002-7959-5881 ; 0000-0002-1091-4733</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.16468$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.16468$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32294258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Messina, F.</creatorcontrib><creatorcontrib>Piaserico, S.</creatorcontrib><title>SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Adult</subject><subject>Arthritis, Psoriatic - diagnosis</subject><subject>Arthritis, Psoriatic - drug therapy</subject><subject>Arthritis, Psoriatic - immunology</subject><subject>Biological Products - administration & dosage</subject><subject>Biological Products - adverse effects</subject><subject>Clinical Laboratory Techniques</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - immunology</subject><subject>COVID-19</subject><subject>COVID-19 Testing</subject><subject>Covid‐19 Special Forum</subject><subject>False Negative Reactions</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunocompromised Host - immunology</subject><subject>Interleukin-23 - antagonists & inhibitors</subject><subject>Italy</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - immunology</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - immunology</subject><subject>Risk Assessment</subject><subject>Severe Acute Respiratory Syndrome - diagnosis</subject><subject>Severe Acute Respiratory Syndrome - therapy</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOAjEUhhujEUQXvoCZrYuBXqal3ZgQvGGIJqJsm7bTkRKYmXRGCDsfwWf0SSyOEl3YxTlN-p2vJz8Apwh2UTi9ebrqIpYwvgfaKLSYQE72QRsKzGIhqGiBo6qaQwgRovwQtAjGIsGUt8H9ZPA4-Xh7HxbTUHHk8sya2hV5uEUqKqvCO1U7E5Wh2ryOam9VbdNo7epZNBpvh0hgZ067uvDH4CBTi8qefPcOeL6-ehrexuOHm9FwMI5NkhAeI97PNFeCQJwgbajOKIWUGy0Ig5AZkhJhqE0RzxIj-ikOSxkhtOJKcwYN6YCLxlu-6qVNTdjMq4UsvVsqv5GFcvLvS-5m8qVYyT5mGFEWBOeNwPiiqrzNdrMIym2oMoQqv0IN7Nnvz3bkT4oB6DXA2i3s5n-TvLucNspP_SmEqA</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Messina, F.</creator><creator>Piaserico, S.</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7959-5881</orcidid><orcidid>https://orcid.org/0000-0002-1091-4733</orcidid></search><sort><creationdate>202006</creationdate><title>SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor</title><author>Messina, F. ; Piaserico, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4438-187fb8a930241bc5bf55058cb936006c3d39c5ed18f4c97d2fecc99ba8ab860c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Arthritis, Psoriatic - diagnosis</topic><topic>Arthritis, Psoriatic - drug therapy</topic><topic>Arthritis, Psoriatic - immunology</topic><topic>Biological Products - administration & dosage</topic><topic>Biological Products - adverse effects</topic><topic>Clinical Laboratory Techniques</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - immunology</topic><topic>COVID-19</topic><topic>COVID-19 Testing</topic><topic>Covid‐19 Special Forum</topic><topic>False Negative Reactions</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunocompromised Host - immunology</topic><topic>Interleukin-23 - antagonists & inhibitors</topic><topic>Italy</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - immunology</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - immunology</topic><topic>Risk Assessment</topic><topic>Severe Acute Respiratory Syndrome - diagnosis</topic><topic>Severe Acute Respiratory Syndrome - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Messina, F.</creatorcontrib><creatorcontrib>Piaserico, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Messina, F.</au><au>Piaserico, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>34</volume><issue>6</issue><spage>e254</spage><epage>e255</epage><pages>e254-e255</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>32294258</pmid><doi>10.1111/jdv.16468</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-7959-5881</orcidid><orcidid>https://orcid.org/0000-0002-1091-4733</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2020-06, Vol.34 (6), p.e254-e255 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7262156 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - immunology Biological Products - administration & dosage Biological Products - adverse effects Clinical Laboratory Techniques Coronavirus Infections - diagnosis Coronavirus Infections - immunology COVID-19 COVID-19 Testing Covid‐19 Special Forum False Negative Reactions Female Follow-Up Studies Humans Immunocompromised Host - immunology Interleukin-23 - antagonists & inhibitors Italy Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - immunology Psoriasis - diagnosis Psoriasis - drug therapy Psoriasis - immunology Risk Assessment Severe Acute Respiratory Syndrome - diagnosis Severe Acute Respiratory Syndrome - therapy |
| title | SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐23 inhibitor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A30%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS%E2%80%90CoV%E2%80%902%20infection%20in%20a%20psoriatic%20patient%20treated%20with%20IL%E2%80%9023%20inhibitor&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Messina,%20F.&rft.date=2020-06&rft.volume=34&rft.issue=6&rft.spage=e254&rft.epage=e255&rft.pages=e254-e255&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.16468&rft_dat=%3Cwiley_pubme%3EJDV16468%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32294258&rfr_iscdi=true |